Neovascular age-related macular degeneration is a medical condition with active clinical research programs worldwide.

18 total trials for this combination

Showing top 10 of 18 trials

Trials

NCT ID	Title	Status	Phase
NCT06495918	Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration	ACTIVE_NOT_RECRUITING	PHASE3
NCT03683251	Extension Study for the Port Delivery System With Ranibizumab (Portal)	RECRUITING	—
NCT05904028	Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD	RECRUITING	PHASE3
NCT04704921	Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD	RECRUITING	PHASE2/PHASE3
NCT04757610	OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)	TERMINATED	PHASE3
NCT06491914	A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)	ACTIVE_NOT_RECRUITING	PHASE3
NCT03677934	A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration	COMPLETED	PHASE3
NCT03630952	Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)	TERMINATED	PHASE3
NCT06190093	A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)	COMPLETED	PHASE3
NCT06223958	Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration	ACTIVE_NOT_RECRUITING	PHASE3

Related Pages

All Neovascular age-related macular degeneration trials All trials in Bellaire, United States